SSTR2

SSTR2 (somatostatin receptor 2) is a G protein-coupled receptor that mediates the biological actions of somatostatin and functions as a major regulator of hormone secretion, neuroendocrine signaling, and cellular homeostasis^[1][2]. Mechanistically, SSTR2 couples to inhibitory signaling pathways and exhibits subtype-specific signal transduction properties, including regulation of ERK-dependent pathways and other downstream effectors involved in cellular responses^[2][3][4]. Through these signaling networks, SSTR2 can suppress cell proliferation and influence endocrine feedback circuits, supporting its central role in neuroendocrine physiology^[3][5]. Disease relevance is particularly evident in pituitary adenomas and gastroenteropancreatic neuroendocrine tumors, where SSTR2 is frequently expressed and serves as an important molecular target for diagnosis and therapeutic intervention^[5][6][7]. Experimental studies further demonstrate that loss of SSTR2 alters glucagon regulation, growth hormone feedback mechanisms, and multiple physiological processes in knockout models, highlighting its functional significance in vivo^[5]. Compared with related somatostatin receptor isoforms, SSTR2 possesses distinct signaling characteristics and tissue distribution patterns, while alternative splice variants SSTR2A and SSTR2B show only minimal differences in receptor operational properties^[2][8]. For experimental and translational applications, SSTR2-selective agonists and clinically used somatostatin analogs, including octreotide-based approaches, have enabled receptor-targeted imaging, radionuclide therapy, and hormone-suppressive strategies in SSTR2-positive tumors^[5][6][7].